Items where Author is "Schmidt-Erfurth, U."

2011

Ritter, M. and Sacu, S. and Matt, G. and Dunavölgyi, R. and Bühl, W. and Prünte, C. and Schmidt-Erfurth, U.. (2011) Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane : a randomized, controlled clinical study. Eye, Vol. 25, H. 10. pp. 1284-1293.

2010

Bolz, M. and Simader, C. and Ritter, M. and Ahlers, C. and Benesch, T. and Prünte, C. and Schmidt-Erfurth, U.. (2010) Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration. British journal of ophthalmology, Vol. 94, no. 2. pp. 185-189.

Mitchell, P. and Korobelnik, J.-F. and Lanzetta, P. and Holz, F. G. and Prünte, C. and Schmidt-Erfurth, U. and Tano, Y. and Wolf, S.. (2010) Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. British journal of ophthalmology, Vol. 94, no. 1. pp. 2-13.

Matt, G. and Sacu, S. and Stifter, E. and Prünte, C. and Schmidt-Erfurth, U.. (2010) [Combination of Intravitreal rTPA, gas and ranibizumab for extensive subfoveal haemorrhages secondary to neovascular age-related macular degeneration]. Klinische Monatsblätter für Augenheilkunde, Vol. 227, H. 3. pp. 221-225.

2009

Golbaz, I. and Ahlers, C. and Schütze, C. and Stock, G. and Mylonas, G. and Prünte, C. and Schmidt-Erfurth, U.. (2009) Beeinflussung von Netzhautdickenwerten durch antiangiogenetische Therapie bei altersbedingter Makuladegeneration. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Vol. 106. pp. 1103-1110.

Georgopoulos, M. and Polak, K. and Prager, F. and Prünte, C. and Schmidt-Erfurth, U.. (2009) Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). British journal of ophthalmology, Vol. 93. pp. 457-462.

Sacu, S. and Stifter, E. and Vécsei-Marlovits, P. V. and Michels, S. and Schütze, C. and Prünte, C. and Schmidt-Erfurth, U.. (2009) Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration. Eye : the scientific journal of the Royal College of Ophthalmologists, Vol. 23. pp. 1404-1410.

Sacu, S. and Michels, S. and Prager, F. and Weigert, G. and Dunavoelgyi, R. and Geitzenauer, W. and Pruente, C. and Schmidt-Erfurth, U.. (2009) Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results. Eye : the scientific journal of the Royal College of Ophthalmologists, Vol. 23. pp. 2223-2227.

2008

Ahlers, C. and Golbaz, I. and Stock, G. and Fous, A. and Kolar, S. and Pruente, C. and Schmidt-Erfurth, U.. (2008) Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration. Ophthalmology, Vol. 115 , e39-46.

Bolz, M. and Ritter, M. and Polak, K. and Ahlers, C. and Hirn, C. and Prünte, C. and Golbaz, I. and Benesch, T. and Schmidt-Erfurth, U.. (2008) [The role of Stratus OCT in anti-VEGF therapy. Qualitative and quantitative assessment of neovascular AMD]. Der Ophthalmologe, Vol. 105, H. 7. pp. 650-655.